Finnish sauna bathing, a traditional practice involving dry heat exposure, is
associated with significant cardiovascular benefits, especially in lowering the risk of
hypertension and reducing cardiovascular disease mortality. Longitudinal cohort
studies demonstrate that frequent sauna use (4–7 sessions/week) lowers incident
hypertension risk by 47% (HR: 0.54, 95% CI: 0.32–0.91) and reduces sudden cardiac
death risk by 63% (HR: 0.37, 95% CI: 0.18–0.75) via mechanisms including enhanced
endothelial nitric oxide bioavailability, peripheral vasodilation, and improved
autonomic regulation. Synergistic interactions with cardiorespiratory fitness further
enhance the benefits, with high fitness levels combined with frequent sauna use
being associated with 69% lower cardiovascular disease (CVD) mortality.
Mechanistically, acute sauna exposure induces plasma volume redistribution (70%
cutaneous blood flow increase) and chronic adaptations such as heat shock protein
upregulation, reducing oxidative stress and arterial stiffness. Despite these benefits,
sauna bathing poses risks for specific cardiovascular populations: unstable angina,
recent myocardial infarction (<3–6 months), and severe aortic stenosis are absolute
contraindications due to hemodynamic instability, while decompensated heart
failure and orthostatic hypotension necessitate caution. Clinical trials highlight
transient myocardial ischemia in 93% of stable coronary artery disease patients
during sauna use, underscoring the need for individualized protocols. This review
synthesizes evidence supporting sauna therapy as a non-pharmacological adjunct
for cardiovascular health while emphasizing safety considerations in high-risk
cohorts.
Keywords: sauna, Finnish sauna, cardiovascular diseases
